William L. Macias - 05 Nov 2021 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Chief Medical Officer
Signature
/s/ Eva Renee Barnett, attorney-in-fact for William L. Macias
Issuer symbol
IMVT
Transactions as of
05 Nov 2021
Net transactions value
$0
Form type
4
Filing time
09 Nov 2021, 13:09:08 UTC
Previous filing
16 Sep 2021
Next filing
07 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Award $0 +112,108 +100% $0.000000 224,153 05 Nov 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMVT Stock Option (right to buy) Award $0 +167,325 $0.000000 167,325 05 Nov 2021 Common Stock 167,325 $8.58 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying restricted stock units awards ("RSUs").
F2 The RSUs vest in their entirety on January 1, 2023, subject to the Reporting Person providing continuous service to the Issuer as of such date.
F3 Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on October 25, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney